Completed PHASE3 INTERVENTIONAL 2-arm NCT00362323

Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO

A Randomized, Double-blind Study Comparing the Efficacy and Safety of a Fixed Combination of Fenofibrate and Metformin vs Metformin Alone in Patients With Type 2 Diabetes Mellitus and Dyslipidemia Not Appropriately Controlled With a Statin.

Sponsor: Solvay Pharmaceuticals

Conditions Dyslipidemia/Glucose Metabolism Disorder

Interventions Metformin fenofibrate (F) + metformin (M) hydrochloride fixed combination

Updated 6 times since 2017 Last updated: Apr 15, 2010 Started: Oct 31, 2006 Primary completion: Aug 31, 2008 Completion: Mar 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Dyslipidemia/Glucose Metabolism Disorder, this trial is completed. The trial is conducted by Solvay Pharmaceuticals and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Solvay Pharmaceuticals

Data source: Solvay Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bailleul, France , Balatonfüred, Hungary , Bangalore, India , Bialystok, Poland , Bondy, France , Bratislava, Slovakia , Brno, Czechia , Budapest, Hungary , Bydgoszcz, Poland , Chennai, India and 35 more locations